Results 71 to 80 of about 1,157 (167)
Background: Hemolysis due to ABO incompatibility is an important differential diagnosis in newborns presenting with jaundice. Clinical studies evaluating ABO hemolytic disease of fetus and newborn (ABO-HDFN) question the diagnostic value of the direct ...
Samira Ali Abbas +8 more
doaj +1 more source
– The yearly incidence of anti‐red blood cell antibodies stratified by participant groups and temporal evolution. – Overall significance p = 3.756 × 10−29. ABSTRACT Background Blood transfusion therapies are of vital importance for many patient groups.
Milanka Milosavić +3 more
wiley +1 more source
The primary objective was to explore perinatal and neonatal outcomes amongst infants who received intrauterine transfusion (IUT) for the management of hemolytic disease of the fetus and newborn (HDFN).
Ursula Blyth (13818087) +4 more
core +1 more source
Objective To analyze the application of serological test results in the diagnosis and treatment of anti-M-induced hemolytic disease of the fetus and newborn(HDFN), and to explore HDFN prevention strategies.
Hecai YANG +7 more
doaj +1 more source
Abstract Background Massive fetomaternal hemorrhage can lead to significant fetal morbidity or mortality. RhD negative patients require appropriate treatment to prevent alloimmunization in subsequent pregnancies. Few cases with follow‐up into future pregnancies have been reported.
Sajjad Hassan +4 more
wiley +1 more source
ABO hemolytic disease of the fetus and newborn (HDFN) generally occurs due to transplacental passage of maternal IgG ABO antibodies causing fetal and newborn red cell hemolysis.
V. K. Nayana +5 more
doaj +1 more source
Hemolytic disease of the fetus and newborn: A review of pathophysiology, diagnosis, and management
Hemolytic Disease of the Fetus and Newborn (HDFN) results from maternal alloantibodies attacking fetal red blood cells, leading to fetal anemia and potentially severe complications such as hydrops fetalis.
Malik, Hajram +2 more
core +1 more source
BACKGROUND: The clinical significance of serologic reactivity of unidentified specificity (SRUS) in pregnancy is not clear based on available literature.
Pagano, Monica B +20 more
core
Noninvasive approach for the management of hemolytic disease of the fetus
Hemolytic disease of the fetus and newborn (HDFN) is due to maternal alloantibodies directed against paternally inherited antigens on fetal red cells, and it is still a problem in affected pregnancies despite the routine use of anti-D immunoglobulin ...
Soothill, PW +3 more
core +1 more source

